持续性质量管理在医院抗肿瘤药物中的新型实践
|
摘要
目的规范抗肿瘤药物的应用,保障患者用药安全以及减少对医护人员的职业危害。方法发现抗肿瘤药物使用中的问题,针对问题采取相应的措施。结果从处方审核、调配核对、药品使用方面完善抗肿瘤药物的管理。建立用药决策系统,实现事前处方审核和事中审方互动,提高审方效率与合理用药水平;改进调配核对操作,减少抗肿瘤药物对环境和医护人员的危害;加强药学服务,增进药师与医、护、患的关系,共同促进临床的合理用药。结论不断发现和解决抗肿瘤药物应用中的问题,有助于规范抗肿瘤药物的质量管理,减少对患者及医护人员的危害。
Objective To standardize the application of antineoplastic agents, to ensure the safety of patients' medication and to reduce occupational hazards to medical staff. Methods Problems in the use of antineoplastic agents were found out and corresponding measures were therefore carried out. Results The quality management of antineoplastic agents was improved in the aspects of prescription checking,drug dispensing and usage. The establishment of medication decision-making system realized the pre-prescription checking and interacting review in the matter. It improved the efficiency of prescription checking and the level of rational drug usage. The improvement of drug dispensing and verification reduces the harm of anti-tumor drugs to the environment and medical staff. The enhancement of pharmaceutical services improved the relationship with doctors, nurses as well as patients, which promoted the rational use of drugs in clinic. Conclusion Constantly discovering and solving problems during the application of drugs will help regulate the quality management of antineoplastic agents and reduce the hazard to patients and medical staff.
Objective To standardize the application of antineoplastic agents, to ensure the safety of patients' medication and to reduce occupational hazards to medical staff. Methods Problems in the use of antineoplastic agents were found out and corresponding measures were therefore carried out. Results The quality management of antineoplastic agents was improved in the aspects of prescription checking,drug dispensing and usage. The establishment of medication decision-making system realized the pre-prescription checking and interacting review in the matter. It improved the efficiency of prescription checking and the level of rational drug usage. The improvement of drug dispensing and verification reduces the harm of anti-tumor drugs to the environment and medical staff. The enhancement of pharmaceutical services improved the relationship with doctors, nurses as well as patients, which promoted the rational use of drugs in clinic. Conclusion Constantly discovering and solving problems during the application of drugs will help regulate the quality management of antineoplastic agents and reduce the hazard to patients and medical staff.
引文
[1]Hall AL, Demers PA, Astrakianakis G, et al. Estimating National-Level Exposure to Antineoplastic Agents in the Workplace:CAREX Canada Findings and Future Research Needs[J]. Ann Work Expo Health, 2017, 61(6):656-658.doi:10.1093/annweh/wxx042.
[2]韩杰霞,杨秀萍.三级医院门诊药房实时审方系统应用前后效果分析[J].天津药学, 2017, 29(4):51-53.
[3]孙翠萍,严定强,杨军军.风险管理在预防PIVAS抗肿瘤药物职业危害中的应用[J].药学与临床研究, 2017,25(3):271-274.
[4]包健安,沈国荣,王人英,等.多中心PIVAS集中调配人员抗肿瘤药物职业暴露评估[J].中国医院药学杂志,2016, 36(9):701-706. doi:10.13286/j. cnki. chinhosppharmacyj.2016.09.01.
[5]马丽媛.我国药学服务研究的内容与发展趋势[J].中国药物与临床, 2016, 16(6):908-909. doi:10.11655/zgywylc2016.06.063.
[6]杨全军,郭澄,徐嵘,等.我院事前实时干预、事中互动审方和事后点评分析一体化用药决策系统的建设[J].中国药房, 2017, 28(35):5016-5019. doi:10.6039/j.issn.1001-0408.2017.35.33.
[7]庞露,刘立民,肇丽梅.大剂量甲氨蝶呤排泄延迟影响因素的研究进展[J].中国药学杂志, 2013, 48(22):1892-1896. doi:10.11669/cpj.2013.22.002.
[8]王程程,彭媛,陈芙蓉,等.肿瘤联合化疗与用药顺序[J].中国药房, 2013, 24(26):2470-2472. doi:10.6039/j.issn.1001-0408.2013.26.27.
[9]杨辉,尹航,崔向丽,等.临床药师用药教育对患者获益影响的系统评价与Meta分析[J].中国新药杂志2017,26(7):831-836.
[10]李志勇,廖华,麦卫校,等.用药教育对肿瘤化疗患者生存质量的影响[J].中国医药指南, 2013, 11(23):786.
[11]杨晓荣,周燕萍,任艳.抗肿瘤药物临床应用的安全管理问题及对策[J].中国药业, 2015, 24(20):94-96.
[2]韩杰霞,杨秀萍.三级医院门诊药房实时审方系统应用前后效果分析[J].天津药学, 2017, 29(4):51-53.
[3]孙翠萍,严定强,杨军军.风险管理在预防PIVAS抗肿瘤药物职业危害中的应用[J].药学与临床研究, 2017,25(3):271-274.
[4]包健安,沈国荣,王人英,等.多中心PIVAS集中调配人员抗肿瘤药物职业暴露评估[J].中国医院药学杂志,2016, 36(9):701-706. doi:10.13286/j. cnki. chinhosppharmacyj.2016.09.01.
[5]马丽媛.我国药学服务研究的内容与发展趋势[J].中国药物与临床, 2016, 16(6):908-909. doi:10.11655/zgywylc2016.06.063.
[6]杨全军,郭澄,徐嵘,等.我院事前实时干预、事中互动审方和事后点评分析一体化用药决策系统的建设[J].中国药房, 2017, 28(35):5016-5019. doi:10.6039/j.issn.1001-0408.2017.35.33.
[7]庞露,刘立民,肇丽梅.大剂量甲氨蝶呤排泄延迟影响因素的研究进展[J].中国药学杂志, 2013, 48(22):1892-1896. doi:10.11669/cpj.2013.22.002.
[8]王程程,彭媛,陈芙蓉,等.肿瘤联合化疗与用药顺序[J].中国药房, 2013, 24(26):2470-2472. doi:10.6039/j.issn.1001-0408.2013.26.27.
[9]杨辉,尹航,崔向丽,等.临床药师用药教育对患者获益影响的系统评价与Meta分析[J].中国新药杂志2017,26(7):831-836.
[10]李志勇,廖华,麦卫校,等.用药教育对肿瘤化疗患者生存质量的影响[J].中国医药指南, 2013, 11(23):786.
[11]杨晓荣,周燕萍,任艳.抗肿瘤药物临床应用的安全管理问题及对策[J].中国药业, 2015, 24(20):94-96.